Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia

Movement Disorders

Volumn 23, Issue 13, 2008, Pages 1889-1896

  Kulisevsky, Jaime ^a   Pagonbarraga, Javier ^a   Pascual Sedano, Berta ^a   García Sánchez, Carmen ^a   Gironell, Alexandre ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Apathy; Cluster; Hallucinations; Neuropsychiatry; Parkinson

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BROMOCRIPTINE; CABERGOLINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; NEUROLEPTIC AGENT; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; SELEGILINE;

AGED; ANXIETY DISORDER; APATHY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DAYTIME SOMNOLENCE; DELUSION; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DYSPHORIA; EPWORTH SLEEPINESS SCALE; EUPHORIA; FEMALE; HALLUCINATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL PERFORMANCE; MONOTHERAPY; PARKINSON DISEASE; PHONEME; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; SEMANTICS; VERBAL BEHAVIOR;

AFFECT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; DEMENTIA; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MENTAL DISORDERS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PREVALENCE; PROBLEM SOLVING;

EID: 57049121696     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22246     Document Type: Article

References (41)

1. Aarsland D, Larsen JP, Lim NG, et al. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;67:492-496.
2. Aarsland D, Bronnick K, Ehrt U, et al. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 2007;78:36-42.
3. Karlsen KH, Tandberg E, Arsland D, Larsen JP. Health related quality of life in Parkinson's disease: a prospective longitudinal study. J Neurol Neurosurg Psychiatry 2000;69: 584-589.
4. Schrag A, Jahanshahi M, Quinn NP. What contributes to depression in Parkinson's disease? Psychol Med 2001;31:65-73.
5. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol 2003;2:229-237.
6. Bronnick K, Aarsland D, Larsen JP. Neuropsychiatric disturbances in Parkinson's disease clusters in five groups with different prevalence of dementia. Acta Psychiatr Scand Suppl 2005;112: 201-207.
7. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005;65:1239-1245.
8. Gjerstad MD, Aarsland D, Larsen JP. Development of daytime somnolence over time in Parkinson's disease. Neurology 2002;58:1544-1546.
9. Foltynie T, Brayne C, Barker RA. The heterogeneity of idiopathic Parkinson's disease. J Neurol 2002;249:138-145.
10. Everitt BS, Landau S. The use of multivariate statistical methods in psychiatry. Stat Methods Med Res 1998;7:253-277.
11. Grandas F, Kulisevsky J. Treatment of Parkinson's disease in Spain. Mov Disord 2003;18:87-89.
12. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
13. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, D.C., US: American Psychiatric Association; 1994.
14. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
15. Vilalta-Franch J, Lozano-Gallego M, Hernández-Ferrándiz M, Llinás-Reglá J, López-Pousa S, López OL. The neuropsychiatric inventory. Psychometric properties of its adaptation into Spanish. Rev Neurol 1999;29:15-19.
16. Kulisevsky J, Litvan I, Berthier ML, Pascual-Sedano B, Paulsen JS, Cummings JL. Neuropsychiatric assessment of Gilles de la Tourette patients: comparative study with other hyperkinetic and hypokinetic movement disorders. Mov Disord 2001;16:1098-1104.
17. Shallice T, Burgess P. The domain of supervisory processes and temporal organization of behaviour. Philos Trans R Soc Lond B Biol Sci 1996;351:1405-1411, discussion 1411-1402.
18. Bak TH, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase 2005;11:268-273.
19. Lange KW, Tucha O, Alders GL, et al. Differentiation of parkinsonian syndromes according to differences in executive functions. J Neural Transm 2003;110:983-995.
20. Gironell A, Kulisevsky J, Rami L, Fortuny N, Garcia-Sanchez C, Pascual-Sedano B. Effects of pallidotomy and bilateral subthalamic stimulation on cognitive function in Parkinson disease. A controlled comparative study. J Neurol 2003;250:917-923.
21. Downes JJ, Sharp HM, Costall BM, Sagar HJ, Howe J. Alternating fluency in Parkinson's disease. An evaluation of the attentional control theory of cognitive impairment. Brain 1993;116 (Part 4):887-902.
22. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 2000;55:1621-1626.
23. Orgogozo JM, van Drimmelen-Krabbe J, Bradley WG, L'Hours A, Sartorius N. The international classification of WHO diseases (ICD-10) and its application in neurology (ICD-10 NA)]. Rev Neurol (Paris) 1994;150:813-822.
24. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
25. Marinus J, Leentjens AF, Visser M, Stiggelbout AM, van Hilten JJ. Evaluation of the hospital anxiety and depression scale in patients with Parkinson's disease. Clin Neuropharmacol 2002;25: 318-324.
26. Mondolo F, Jahanshahi M, Grana A, Biasutti E, Cacciatori E, Di Benedetto P. The validity of the hospital anxiety and depression scale and the geriatric depression scale in Parkinson's disease. Behav Neurol 2006;17:109-115.
27. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-545.
28. Borek LL, Kohn R, Friedman JH. Mood and sleep in Parkinson's disease. J Clin Psychiatry 2006;67:958-963.
29. Hobson DE, Lang AE, Martin WR, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 2002;287:455-463.
30. Santamaria J. How to evaluate excessive daytime sleepiness in Parkinson's disease. Neurology 2004;63:S21-S23.
31. Roth T, Rye DB, Borchert LD, et al. Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists. Sleep Med 2003;4:275-280.
32. Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry 2000;157:708-714.
33. Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005;128:1314-1322.
34. Dailly E, Chenu F, Renard CE, Bourin M. Dopamine, depression and antidepressants. Fundam Clin Pharmacol 2004;18:601-607.
35. Kulisevsky J, Pascual-Sedano B, Barbanoj M, Gironell A, Pagonabarraga J, Garcia-Sanchez C. Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: A double-blind study. Mov Disord 2007;22:62-67.
36. Williams DR, Lees AJ. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol 2005;4:605-610.
37. Levy ML, Cummings JL, Fairbanks LA, et al. Apathy is not depression. J Neuropsychiatry Clin Neurosci 1998;10:314-319.
38. Pluck GC, Brown RG. Apathy in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002;73:636-642.
39. Kirsch-Darrow L, Fernandez HH, Marsiske M, Okun MS, Bowers D. Dissociating apathy and depression in Parkinson disease. Neurology 2006;67:33-38.
40. Dujardin K, Sockeel P, Devos D, et al. Characteristics of apathy in Parkinson's disease. Mov Disord 2007;22:778-784.
41. Galvin JE, Pollack J, Morris JC. Clinical phenotype of Parkinson disease dementia. Neurology 2006;67:1605-1611.